Global HIV-1 Screening Tests Market By Product Type (ELISA, Rapid Tests) And By End-Users/Application (Hospital, Clinic) Global Market Share, Forecast Data, In-Depth Analysis, And Detailed Overview, and Forecast, 2013 - 2026

According to Apex Market Research the HIV-1 Screening Tests market was valued at USD xx.xx million in 2019 and is anticipated to grow at a CAGR of xx% during the forecast period from 2020 to 2028. The report on HIV-1 Screening Tests market delivers detailed analysis covering major regional trends, market dynamics, and offer country-level market value of HIV-1 Screening Tests industry. Some of the major aspects considered during the course of research comprises definition of the product, classification of the product, industry structure, different participants in the HIV-1 Screening Tests ecosystem, etc. The report comprises of market value and forecast for the period from 2020 to 2028, CAGR measured for individual segment and regional market, competitive landscape of key market players, and profiling of major providers participating in the HIV-1 Screening Tests market.

The following manufacturers are covered in this report:
  • Siemens AG (Germany)
  • Roche Diagnostics (Switzerland)
  • Abbott Laboratories (U.S)
  • Danaher Corporation (U.S.)
  • Thermo-Fisher Scientific Inc. (U.S.)
  • Merck KGaA (Germany)
  • Becton, Dickinson and Company (U.S.)
  • Hologic, Inc. (U.S.)
  • Alere Inc. (U.S.)
  • Bio-Rad Laboratories (U.S.)

The report estimates on the HIV-1 Screening Tests market economy trend, market numbers (Mn/Bn USD) and CAGR from the 2020-2028, considering 2019 as the base year. A global HIV-1 Screening Tests market report consist of all leading industry players, HIV-1 Screening Tests business sections, company profile, revenue supply by HIV-1 Screening Tests industry sections, global HIV-1 Screening Tests market trends, acquisitions and arrangements, contact info, recent development, geographic examination and even more using the assistance.

Since the onset of COVID-19 in December 2019, the governments of various countries declared lockdown and as result numerous economies around the world experienced severe economic downturn. Since early 2020, the HIV-1 Screening Tests market witnessed the impact of COVID-19 The report objects to provide pre-COVID-19 state of the HIV-1 Screening Tests market in years 2020 and 2019 and moreover it offers forecast for the Covid-19 period from 2020 to 2028.The report provides COVID-19 impact on HIV-1 Screening Tests market, global analysis, different challenges or threats and opportunities for stakeholders involved in the HIV-1 Screening Tests market.

Report Opportunity: Global HIV-1 Screening Tests Market

This report delivers an analytical examination of the HIV-1 Screening Tests market summarized in broad sections such as
  1. HIV-1 Screening Tests Market Summary
  2. Key Commercial Growths in the HIV-1 Screening Tests Industry
  3. Market Dynamics Affecting the HIV-1 Screening Tests Industry
  4. Important Market Trends and Future Development Scenario of the HIV-1 Screening Tests Market
  5. HIV-1 Screening Tests Market Revenue and Forecast, by Type, 2018 – 2028
  6. Competitive Landscape of HIV-1 Screening Tests Industry
  7. Positioning of Main Market Players in the HIV-1 Screening Tests Industry
  8. HIV-1 Screening Tests Market Revenue and Forecast, by Application, 2018 - 2028
  9. HIV-1 Screening Tests Market Revenue and Forecast, by End-use, 2018 - 2028
  10. HIV-1 Screening Tests Market Revenue and Forecast, by Geography, 2018 - 2028
HIV-1 Screening Tests Market Segmentation:

The report provides detailed examination of the HIV-1 Screening Tests market on the basis of various segments such as type, application and end-use industry. The HIV-1 Screening Tests market is segmented as follows:

HIV-1 Screening Tests Market, by Type:
  • ELISA
  • Rapid Tests
  • Home Access Dried Blood Spot
HIV-1 Screening Tests Market, by Application:
  • Hospital
  • Clinic
  • Others
Geographic Coverage

The report on the HIV-1 Screening Tests market delivers an in depth country-level cross-sectional analysis across different regions around the globe. The report comprises of complete market value and forecast for the following countries and regions:

North America HIV-1 Screening Tests Market Revenue and Forecast
  • U.S.
  • Canada
Europe HIV-1 Screening Tests Market Revenue and Forecast
  • UK
  • Germany
  • France
  • Rest of Europe
Asia Pacific HIV-1 Screening Tests Market Revenue and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific
Latin America HIV-1 Screening Tests Market Revenue and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America
Middle East and Africa HIV-1 Screening Tests Market Revenue and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summary
     2.1. Global HIV-1 Screening Tests Market Snapshot
          2.1.1. Global HIV-1 Screening Tests Market By Type,2019
               2.1.1.1.ELISA
               2.1.1.2.Rapid Tests
               2.1.1.3.Home Access Dried Blood Spot
          2.1.2. Global HIV-1 Screening Tests Market By Application,2019
               2.1.2.1.Hospital
               2.1.2.2.Clinic
               2.1.2.3.Others
          2.1.3. Global HIV-1 Screening Tests Market By End-use,2019
          2.1.4. Global HIV-1 Screening Tests Market By Geography,2019

3. Global HIV-1 Screening Tests Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global HIV-1 Screening Tests Market Size (US$), By Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Type, 2020
     4.2. Global HIV-1 Screening Tests Market Size (US$), By Type, 2018 – 2028

5. Global HIV-1 Screening Tests Market Size (US$), By Application, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Application, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Application, 2020
     5.2. Global HIV-1 Screening Tests Market Size (US$), By Application, 2018 – 2028

6. Global HIV-1 Screening Tests Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global HIV-1 Screening Tests Market Size (US$), By End-use, 2018 – 2028

7. Global HIV-1 Screening Tests Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America HIV-1 Screening Tests Market Analysis, 2018 – 2028 
          7.2.1. North America HIV-1 Screening Tests Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America HIV-1 Screening Tests Market Size (US$), By Type, 2018 – 2028
          7.2.3. North America HIV-1 Screening Tests Market Size (US$), By Application, 2018 – 2028
          7.2.4. North America HIV-1 Screening Tests Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe HIV-1 Screening Tests Market Analysis, 2018 – 2028 
          7.3.1.  Europe HIV-1 Screening Tests Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe HIV-1 Screening Tests Market Size (US$), By Type, 2018 – 2028
          7.3.3. Europe HIV-1 Screening Tests Market Size (US$), By Application, 2018 – 2028
          7.3.4. Europe HIV-1 Screening Tests Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific HIV-1 Screening Tests Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific HIV-1 Screening Tests Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific HIV-1 Screening Tests Market Size (US$), By Type, 2018 – 2028
          7.4.3. Asia Pacific HIV-1 Screening Tests Market Size (US$), By Application, 2018 – 2028
          7.4.4. Asia Pacific HIV-1 Screening Tests Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America HIV-1 Screening Tests Market Analysis, 2018 – 2028 
          7.5.1.  Latin America HIV-1 Screening Tests Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America HIV-1 Screening Tests Market Size (US$), By Type, 2018 – 2028
          7.5.3. Latin America HIV-1 Screening Tests Market Size (US$), By Application, 2018 – 2028
          7.5.4. Latin America HIV-1 Screening Tests Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) HIV-1 Screening Tests Market Analysis, 2018 – 2028 
          7.6.1.  MEA HIV-1 Screening Tests Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA HIV-1 Screening Tests Market Size (US$), By Type, 2018 – 2028
          7.6.3. MEA HIV-1 Screening Tests Market Size (US$), By Application, 2018 – 2028
          7.6.4. MEA HIV-1 Screening Tests Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key HIV-1 Screening Tests Providers
        8.4.1 Siemens AG (Germany)
                8.1.1 Business Description
                8.1.2 Siemens AG (Germany) Geographic Operations
                8.1.3 Siemens AG (Germany) Financial Information
                8.1.4 Siemens AG (Germany) Product Positions/Portfolio
                8.1.5 Siemens AG (Germany) Key Developments
        8.4.2 Roche Diagnostics (Switzerland)
                8.2.1 Business Description
                8.2.2 Roche Diagnostics (Switzerland) Geographic Operations
                8.2.3 Roche Diagnostics (Switzerland) Financial Information
                8.2.4 Roche Diagnostics (Switzerland) Product Positions/Portfolio
                8.2.5 Roche Diagnostics (Switzerland) Key Developments
        8.4.3 Abbott Laboratories (U.S)
                8.3.1 Business Description
                8.3.2 Abbott Laboratories (U.S) Geographic Operations
                8.3.3 Abbott Laboratories (U.S) Financial Information
                8.3.4 Abbott Laboratories (U.S) Product Positions/Portfolio
                8.3.5 Abbott Laboratories (U.S) Key Developments
        8.4.4 Danaher Corporation (U.S.)
                8.4.1 Business Description
                8.4.2 Danaher Corporation (U.S.) Geographic Operations
                8.4.3 Danaher Corporation (U.S.) Financial Information
                8.4.4 Danaher Corporation (U.S.) Product Positions/Portfolio
                8.4.5 Danaher Corporation (U.S.) Key Developments
        8.4.5 Thermo-Fisher Scientific Inc. (U.S.)
                8.5.1 Business Description
                8.5.2 Thermo-Fisher Scientific Inc. (U.S.) Geographic Operations
                8.5.3 Thermo-Fisher Scientific Inc. (U.S.) Financial Information
                8.5.4 Thermo-Fisher Scientific Inc. (U.S.) Product Positions/Portfolio
                8.5.5 Thermo-Fisher Scientific Inc. (U.S.) Key Developments
        8.4.6 Merck KGaA (Germany)
                8.6.1 Business Description
                8.6.2 Merck KGaA (Germany) Geographic Operations
                8.6.3 Merck KGaA (Germany) Financial Information
                8.6.4 Merck KGaA (Germany) Product Positions/Portfolio
                8.6.5 Merck KGaA (Germany) Key Developments
        8.4.7 Becton, Dickinson and Company (U.S.)
                8.7.1 Business Description
                8.7.2 Becton, Dickinson and Company (U.S.) Geographic Operations
                8.7.3 Becton, Dickinson and Company (U.S.) Financial Information
                8.7.4 Becton, Dickinson and Company (U.S.) Product Positions/Portfolio
                8.7.5 Becton, Dickinson and Company (U.S.) Key Developments
        8.4.8 Hologic, Inc. (U.S.)
                8.8.1 Business Description
                8.8.2 Hologic, Inc. (U.S.) Geographic Operations
                8.8.3 Hologic, Inc. (U.S.) Financial Information
                8.8.4 Hologic, Inc. (U.S.) Product Positions/Portfolio
                8.8.5 Hologic, Inc. (U.S.) Key Developments
        8.4.9 Alere Inc. (U.S.)
                8.9.1 Business Description
                8.9.2 Alere Inc. (U.S.) Geographic Operations
                8.9.3 Alere Inc. (U.S.) Financial Information
                8.9.4 Alere Inc. (U.S.) Product Positions/Portfolio
                8.9.5 Alere Inc. (U.S.) Key Developments
        8.4.10 Bio-Rad Laboratories (U.S.)
                8.10.1 Business Description
                8.10.2 Bio-Rad Laboratories (U.S.) Geographic Operations
                8.10.3 Bio-Rad Laboratories (U.S.) Financial Information
                8.10.4 Bio-Rad Laboratories (U.S.) Product Positions/Portfolio
                8.10.5 Bio-Rad Laboratories (U.S.) Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global HIV-1 Screening Tests Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America HIV-1 Screening Tests Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America HIV-1 Screening Tests Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 6 North America HIV-1 Screening Tests Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe HIV-1 Screening Tests Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe HIV-1 Screening Tests Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe HIV-1 Screening Tests Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific HIV-1 Screening Tests Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific HIV-1 Screening Tests Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific HIV-1 Screening Tests Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America HIV-1 Screening Tests Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America HIV-1 Screening Tests Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America HIV-1 Screening Tests Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA HIV-1 Screening Tests Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA HIV-1 Screening Tests Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA HIV-1 Screening Tests Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global HIV-1 Screening Tests: Market Segmentation 
FIG. 2 Global HIV-1 Screening Tests Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global HIV-1 Screening Tests Market, By Type, 2019 (US$ Mn) 
FIG. 5 Global HIV-1 Screening Tests Market, By Application, 2019 (US$ Mn) 
FIG. 6 Global HIV-1 Screening Tests Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global HIV-1 Screening Tests Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global HIV-1 Screening Tests Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key HIV-1 Screening Tests Providers, 2019
FIG. 11 Global HIV-1 Screening Tests Market Revenue Contribution, By Type, 2019 & 2028 (Value %) 
FIG. 12 Global HIV-1 Screening Tests Market Revenue Contribution, By Application, 2019 & 2028 (Value %) 
FIG. 13 Global HIV-1 Screening Tests Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America HIV-1 Screening Tests Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe HIV-1 Screening Tests Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific HIV-1 Screening Tests Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America HIV-1 Screening Tests Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA HIV-1 Screening Tests Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the HIV-1 Screening Tests market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 
1856

4772

OUR CLIENT